Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients

The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ESRD Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Staten Island University Hospital

Staten Island, New York, 10305, United States

About this study

The Hb turnover in hemodialysis population is higher than the general population leading to a general believe that HbA1c tend to underestimate mean plasma glucose.

The investigators are trying to define the correlation between mean plasma glucose and HbA1c in the hemodialysis population and trying to study the factors that could affect this correlation (dose of erythropoetin, ret count..) We are trying to see if HbA1c is a better tool to assess glycemic control over 1 month than glycemic control over 3 month.

This clinicaly will translate in obtaining HbA1c more frequently in hemodialysis patients to assess their glycemic control.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age>18
Hemodialysis and diabetic
Lab data are available for more than 6 months

Exclusion criteria

Lab data not available

Treatment and study plan

Primary outcomes

Measure levels of plasma blood glucose and HbA1c

Time frame: 6 month intervals

Secondary outcomes

Measure ferritin, erythropoetin dose, reticulocytes count

Time frame: 6 month intervals

Sponsors and collaborators

Lead sponsor

Northwell Health

Other

Registry information

Official study title

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients.

Important dates

Study start: 2009
Primary completion: 2009
Study completion: 2009
First posted: Jul 6, 2012
Registry last updated: Jul 6, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed